Skip to main content

Research Repository

Advanced Search

EfpA is required for re-growth of Mycobacterium tuberculosis following isoniazid exposure

Roberts, Adam H.; Moon, Christopher W.; Faulkner, Valwynne; Kendall, Sharon L.; Waddell, Simon; Bacon, Joanna

Authors

Adam H. Roberts

Christopher W. Moon

Valwynne Faulkner

Sharon L. Kendall

Simon Waddell

Joanna Bacon



Abstract

Efflux of antibiotics is a survival strategy in bacteria. Mycobacterium tuberculosis has approximately sixty efflux pumps, but little is known about the role of each pump, or which moieties that they efflux. The putative efflux pump, EfpA, is a member of the major facilitator superfamily that has been shown to be essential by saturation transposon mutagenesis studies. It has been implicated in the efflux of the frontline drug isoniazid (INH) in M. tuberculosis. This is supported by evidence from transcriptional profiling that efpA is induced in response to INH exposure. However, its role in physiology and adaptation of M. tuberculosis to antibiotics, have yet to be determined. Here, we describe the repression of efpA using CRISPR interference and the direct effect of this on the ability of M. tuberculosis to survive exposure to INH over a 45-day time-course. We determined that wild-type levels of efpA were required for the recovery of M. tuberculosis cultures following INH exposure and that, after 45-days of INH exposure, no viable colonies were recoverable from efpA-repressed M. tuberculosis cultures. We postulate that EfpA is required for the recovery of M. tuberculosis following INH-exposure and that EfpA may have a role in the development of resistance, during treatment and contributes to relapse in patients.

Citation

Roberts, A. H., Moon, C. W., Faulkner, V., Kendall, S. L., Waddell, S., & Bacon, J. (in press). EfpA is required for re-growth of Mycobacterium tuberculosis following isoniazid exposure. Antimicrobial Agents and Chemotherapy, https://doi.org/10.1128/aac.00261-24

Journal Article Type Article
Acceptance Date Jun 2, 2024
Online Publication Date Jul 22, 2024
Deposit Date Aug 6, 2024
Publicly Available Date Aug 6, 2024
Journal Antimicrobial Agents and Chemotherapy
Print ISSN 0066-4804
Electronic ISSN 1098-6596
Publisher American Society for Microbiology
Peer Reviewed Not Peer Reviewed
DOI https://doi.org/10.1128/aac.00261-24

Files




You might also like



Downloadable Citations